title: An oncologist's perspective on metformin use and acute lymphoblastic leukemia outcomes.
authors.affiliation: Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Eunice S
authors.initials: ES
authors.lastname: Wang
authors.affiliation: Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA meir.wetzler@roswellpark.org.
authors.forename: Meir
authors.initials: M
authors.lastname: Wetzler
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008495:Medical Oncology; D008687:Metformin / Q000008:administration & dosage / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin
keywords: acute lymphoblastic leukemia; insulin; metformin; oncology